| Justin Robert Cusick, CRNA | |
|
8990 Springbrook Dr Nw Ste 250, Coon Rapids, MN 55433-5884 | |
| (763) 398-1176 | |
| Not Available |
| Full Name | Justin Robert Cusick |
|---|---|
| Gender | Male |
| Speciality | Certified Registered Nurse Anesthetist (crna) |
| Experience | 12 Years |
| Location | 8990 Springbrook Dr Nw Ste 250, Coon Rapids, Minnesota |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1043561004 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 163W00000X | Registered Nurse | R160593-8 (Minnesota) | Primary |
| 367500000X | Nurse Anesthetist, Certified Registered | 091716 (Minnesota) | Secondary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Lakeview Memorial Hospital | Stillwater, MN | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Metropolitan Anesthesia Network Llp | 5698689123 | 647 |
| Twin Cities Anesthesia Associates Pc | 9133491194 | 64 |
News Archive
Medyssey Co., Ltd. (Medyssey Spine) today announced a record 112 percent increase in sales in Q4 2010 compared to Q3 2009. Medyssey Spine, privately held, reports year-to-date sales are up 73 percent over 2009, and the company is on pace to achieve its seventh consecutive year of market share growth in the spine market.
Boehringer Ingelheim Pharmaceuticals, Inc. (BIPI) today announced that the U.S. Food and Drug Administration (FDA) has determined that the "essential use" status of Combivent® (ipratropium bromide and albuterol sulfate) Inhalation Aerosol will be effective through December 31, 2013. With this ruling, COMBIVENT will remain on the market and available to the more than two million chronic obstructive pulmonary disease (COPD) patients who rely on it as a bronchodilator.
Autopsy is often an overlooked source of medical insight which may be hindering advances in cardiovascular medicine, according to new research published in a special issue of the American Heart Association's journal Circulation.
A team of researchers from the University of Texas at Austin and the National Institutes of Health have managed to make significant progress in the development of a vaccine against the fast-spreading and virulent COVID-19/Novel coronavirus that started in Wuhan, Hubei province of China in December 2019 and is still infecting thousands.
› Verified 2 days ago
| Entity Name | Metropolitan Anesthesia Network Llp |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1558314427 PECOS PAC ID: 5698689123 Enrollment ID: O20031118000579 |
News Archive
Medyssey Co., Ltd. (Medyssey Spine) today announced a record 112 percent increase in sales in Q4 2010 compared to Q3 2009. Medyssey Spine, privately held, reports year-to-date sales are up 73 percent over 2009, and the company is on pace to achieve its seventh consecutive year of market share growth in the spine market.
Boehringer Ingelheim Pharmaceuticals, Inc. (BIPI) today announced that the U.S. Food and Drug Administration (FDA) has determined that the "essential use" status of Combivent® (ipratropium bromide and albuterol sulfate) Inhalation Aerosol will be effective through December 31, 2013. With this ruling, COMBIVENT will remain on the market and available to the more than two million chronic obstructive pulmonary disease (COPD) patients who rely on it as a bronchodilator.
Autopsy is often an overlooked source of medical insight which may be hindering advances in cardiovascular medicine, according to new research published in a special issue of the American Heart Association's journal Circulation.
A team of researchers from the University of Texas at Austin and the National Institutes of Health have managed to make significant progress in the development of a vaccine against the fast-spreading and virulent COVID-19/Novel coronavirus that started in Wuhan, Hubei province of China in December 2019 and is still infecting thousands.
› Verified 2 days ago
| Entity Name | Nurse Anesthesia Services Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1023010675 PECOS PAC ID: 8628973435 Enrollment ID: O20031204000880 |
News Archive
Medyssey Co., Ltd. (Medyssey Spine) today announced a record 112 percent increase in sales in Q4 2010 compared to Q3 2009. Medyssey Spine, privately held, reports year-to-date sales are up 73 percent over 2009, and the company is on pace to achieve its seventh consecutive year of market share growth in the spine market.
Boehringer Ingelheim Pharmaceuticals, Inc. (BIPI) today announced that the U.S. Food and Drug Administration (FDA) has determined that the "essential use" status of Combivent® (ipratropium bromide and albuterol sulfate) Inhalation Aerosol will be effective through December 31, 2013. With this ruling, COMBIVENT will remain on the market and available to the more than two million chronic obstructive pulmonary disease (COPD) patients who rely on it as a bronchodilator.
Autopsy is often an overlooked source of medical insight which may be hindering advances in cardiovascular medicine, according to new research published in a special issue of the American Heart Association's journal Circulation.
A team of researchers from the University of Texas at Austin and the National Institutes of Health have managed to make significant progress in the development of a vaccine against the fast-spreading and virulent COVID-19/Novel coronavirus that started in Wuhan, Hubei province of China in December 2019 and is still infecting thousands.
› Verified 2 days ago
| Entity Name | Twin Cities Anesthesia Associates Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1982125456 PECOS PAC ID: 9133491194 Enrollment ID: O20170825001436 |
News Archive
Medyssey Co., Ltd. (Medyssey Spine) today announced a record 112 percent increase in sales in Q4 2010 compared to Q3 2009. Medyssey Spine, privately held, reports year-to-date sales are up 73 percent over 2009, and the company is on pace to achieve its seventh consecutive year of market share growth in the spine market.
Boehringer Ingelheim Pharmaceuticals, Inc. (BIPI) today announced that the U.S. Food and Drug Administration (FDA) has determined that the "essential use" status of Combivent® (ipratropium bromide and albuterol sulfate) Inhalation Aerosol will be effective through December 31, 2013. With this ruling, COMBIVENT will remain on the market and available to the more than two million chronic obstructive pulmonary disease (COPD) patients who rely on it as a bronchodilator.
Autopsy is often an overlooked source of medical insight which may be hindering advances in cardiovascular medicine, according to new research published in a special issue of the American Heart Association's journal Circulation.
A team of researchers from the University of Texas at Austin and the National Institutes of Health have managed to make significant progress in the development of a vaccine against the fast-spreading and virulent COVID-19/Novel coronavirus that started in Wuhan, Hubei province of China in December 2019 and is still infecting thousands.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Justin Robert Cusick, CRNA 3514 Cherry Ln Unit A, Woodbury, MN 55129-8794 Ph: (651) 335-1665 | Justin Robert Cusick, CRNA 8990 Springbrook Dr Nw Ste 250, Coon Rapids, MN 55433-5884 Ph: (763) 398-1176 |
News Archive
Medyssey Co., Ltd. (Medyssey Spine) today announced a record 112 percent increase in sales in Q4 2010 compared to Q3 2009. Medyssey Spine, privately held, reports year-to-date sales are up 73 percent over 2009, and the company is on pace to achieve its seventh consecutive year of market share growth in the spine market.
Boehringer Ingelheim Pharmaceuticals, Inc. (BIPI) today announced that the U.S. Food and Drug Administration (FDA) has determined that the "essential use" status of Combivent® (ipratropium bromide and albuterol sulfate) Inhalation Aerosol will be effective through December 31, 2013. With this ruling, COMBIVENT will remain on the market and available to the more than two million chronic obstructive pulmonary disease (COPD) patients who rely on it as a bronchodilator.
Autopsy is often an overlooked source of medical insight which may be hindering advances in cardiovascular medicine, according to new research published in a special issue of the American Heart Association's journal Circulation.
A team of researchers from the University of Texas at Austin and the National Institutes of Health have managed to make significant progress in the development of a vaccine against the fast-spreading and virulent COVID-19/Novel coronavirus that started in Wuhan, Hubei province of China in December 2019 and is still infecting thousands.
› Verified 2 days ago
Mr. Edwin Moenga Barake, Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 11032 Swallow St Nw, Coon Rapids, MN 55433 Phone: 612-730-7706 | |
Kathleen M Mckay, Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 4040 Coon Rapids Blvd Nw # 100, Coon Rapids, MN 55433 Phone: 763-236-9500 | |
Muna Mohamed Mumin, Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 1068 122nd Ave Nw, Coon Rapids, MN 55448 Phone: 612-442-6011 | |
Rebecca Kohegyi, CRNA Registered Nurse Medicare: Accepting Medicare Assignments Practice Location: 4050 Coon Rapids Blvd Nw, Coon Rapids, MN 55433 Phone: 763-236-6000 | |
Mrs. Nancy Lynne Rick, RN, BA Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 11800 Eldorado St Nw, Apt. 302, Coon Rapids, MN 55433 Phone: 612-600-2219 | |
Barbara Hallblade, RN Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 11030 Mississippi Blvd Nw, Ste 328, Coon Rapids, MN 55433 Phone: 612-805-3474 |